The non-HDL-C/HDL-C ratio is a strong and independent predictor of the no-reflow phenomenon in patients with ST-elevation myocardial infarction.
Kenan ToprakMustafa KaplangoraySelahattin AkyolMehmet İnanırTolga MemioğluMustafa Begenç Taşcanovİbrahim Halil AltıparmakAsuman BiçerRecep DemirbağPublished in: Acta cardiologica (2024)
The non-HDL-C/HDL-C ratio can be a strong and independent predictor of NR in STEMI patients and and therefore non-HDL-C/HDL-C ratio may be a useful lipid-based biomarker that can be used in clinical practice to improve the accuracy of risk assessment in patients with STEMI.
Keyphrases
- st elevation myocardial infarction
- percutaneous coronary intervention
- risk assessment
- clinical practice
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- st segment elevation myocardial infarction
- coronary artery disease
- prognostic factors
- acute coronary syndrome
- human health
- fatty acid